Results 61 to 70 of about 196,958 (280)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

New trends in preserving breastfeeding by use of probiotics to prevent mastitis and lactostasis in breastfeeding women

open access: yesМедицинский совет, 2019
The article discusses the unique property of autonomous variability in breast milk composition under the influence of external factors, including endogenous (hormonal) and exogenous (dietary, environmental) factors.
I. N. Zakharova   +2 more
doaj   +1 more source

Developing medical professionalism in future doctors : a systematic review [PDF]

open access: yes, 2010
Objectives There are currently no guidelines on the most effective ways of supporting medical students to develop high standards of medical professionalism.
Doug, Manjo   +5 more
core   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

German ambulatory care physicians' perspectives on continuing medical education - a national survey

open access: yes, 2022
S.259-268Introduction: This survey aimed to investigate German ambulatory physicians' opinions about mandatory continuing medical education (CME) and CME resources shortly before the introduction of mandatory CME in 2004.
Böcken, J.   +7 more
core   +1 more source

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

open access: yesMolecular Oncology, EarlyView.
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski   +10 more
wiley   +1 more source

On the role of topical drugs in the treatment of acute otitis media in children

open access: yesМедицинский совет, 2019
The article presents an overview of modern approaches to diagnosis and treatment of acute otitis media in children. On the basis of the existing clinical recommendations the indications for systemic antibacterial therapy and tympanocentesis are listed ...
D. A. Tulupov   +2 more
doaj   +1 more source

Getting it right: the impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers

open access: yes, 2013
Monica Robotin,1,2 Yumi Patton,3 Jacob George1,4 1School of Medicine, University of Sydney, Sydney, Australia; 2Cancer Council New South Wales, Sydney, Australia; 3Faculty of Engineering, University of New South Wales, Sydney, Australia; 4Storr Liver ...
George J   +3 more
core   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy